- Micro Report
- Open access
- Published:
Moderate ethanol exposure disrupts energy homeostasis between central and peripheral system in APP/PS1 mice
Molecular Brain volume 18, Article number: 21 (2025)
Abstract
To investigate the effects of moderate ethanol exposure on glucose metabolism in APP/PS1 mice, an early-onset Alzheimer’s disease (AD) mouse model, we employed an fluoro-deoxy-glucose (FDG)-micro-positron emission tomography (PET). We also utilized the comprehensive lab animal monitoring system (CLAMS) to measure whole-body energy expenditure and respiratory exchange ratio (RER). We found that ethanol exposure increased glucose metabolism in the brain as measured by FDG-PET. Also, CLAMS data indicated a decrease in RER, suggesting a shift toward fat utilization as the primary energy source. Following ethanol exposure in APP/PS1 mice, these findings reveal a distinct metabolic difference between brain and peripheral tissues.
Main text
AD is characterized by metabolic dysfunction both centrally, in the brain, and peripherally, affecting overall energy homeostasis. One hallmark of AD is impaired glucose metabolism, which can be observed using FDG-PET imaging, particularly in regions like the cortex and hippocampus [1, 2]. Moderate ethanol exposure is known to influence both brain activity and systemic metabolism, yet the effects of ethanol exposure on metabolism in an AD context still need to be explored [3,4,5].
We examined ethanol’s effects on brain and peripheral metabolism in APP/PS1 mice, an AD mouse model [4]. By combining FDG-PET imaging to assess brain glucose metabolism with CLAMS to monitor whole-body energy utilization, it seeks to elucidate the differential effects of ethanol on brain and peripheral metabolism and investigate whether ethanol-induced changes in brain glucose metabolism correlate with shifts in systemic energy balance.
To examine the relevance of ethanol exposure-induced brain glucose metabolism changes to whole-body energy utilization changes in an AD mouse model (pre- vs. post-ethanol exposure), mice were exposed to ethanol at 12–24 weeks of age. FDG-PET and CLAMS were measured before ethanol exposure and at 11 ~ 12 and 24 ~ 25 weeks of age. Male and female APP/PS1 mice were exposed to ethanol vapor or room air using a vapor chamber for 4 h from 9:00 AM to 1:00 PM, followed by exposure to room air for 20 h. Ethanol vapor exposure was conducted under standardized laboratory conditions, and blood ethanol concentration (BEC) was measured at an average of 170 mg/dl (Fig. S1A). This process was repeated 4 consecutive days per week, with 3 days (withdrawal period) spent in the home cage to investigate the long-term effects of ethanol exposure (Fig. 1A) [4]. Additionally, no significant differences in body weight were observed between the Air and EtOH groups during the 12-week exposure period (Fig. S1B).
Effects of chronic ethanol exposure on brain and peripheral metabolism in AD mice. (A) Mice were exposed to ethanol vapor for 12 weeks, and baseline and post-exposure metabolic assessments were performed using FDG-PET for brain glucose metabolism and CLAMS for peripheral energy expenditure. (B) Representative FDG-PET images showing increased glucose uptake in the cortex and hippocampus following ethanol exposure. (C) Ethanol exposure also significantly decreased the respiratory exchange ratio (RER). Data represent mean ± SEM; n = 5 per group. *P < 0.05 comparing each group. See Table S1 for full statistical information
FDG-PET scans revealed significant changes in brain glucose metabolism following ethanol exposure. Figure 1B shows representative standard uptake value ratio (SUVR) images of the cortex and hippocampus before and after ethanol exposure. The SUVR images indicates increased glucose uptake in the hippocampus and cortex, key AD pathology regions. In the cortex, ethanol exposure led to a substantial increase in glucose uptake. Mice showed significantly higher SUVR values after ethanol exposure than pre-exposure (p < 0.01), indicating enhanced metabolic activity in this region. The cortex, a key area affected by AD, displayed a marked response to ethanol, suggesting that ethanol may stimulate brain activity in early-stage AD. Similarly, in the hippocampus, glucose metabolism increased significantly after ethanol exposure (p < 0.05). The hippocampus, heavily implicated in memory and cognitive function, showed enhanced glucose uptake post-exposure, indicating a potential acute metabolic boost from ethanol exposure (Table S1). Both male and female APP/PS1 mice were included in this study, and initial statistical analyses indicated no significant interaction between sex and treatment (Fig. S1C).
CLAMS data in Fig. 1C show significant changes in peripheral metabolism before and after ethanol exposure. The RER, which reflects the balance between carbohydrate and fat metabolism, decreased notably following ethanol exposure. Before ethanol exposure, RER values indicated a relatively balanced use of carbohydrates and fats for energy, with higher RER values during feeding periods. After ethanol exposure, a significant reduction in RER was observed, particularly during the day and night phases. This decrease suggests a shift toward greater fat oxidation as the primary energy source after moderate ethanol exposure (p < 0.05). These metabolic shifts, characterized by a decrease in RER, suggest that ethanol exposure triggers a reliance on fat metabolism in peripheral tissues, likely due to the increased energy demands of ethanol metabolism and its effects on liver function. The reduction in RER values was consistent across feeding and fasting periods, indicating a persistent shift in peripheral energy balance (Table S1).
The contrasting results from FDG-PET and CLAMS highlight the complex metabolic interplay between the brain and peripheral tissues following ethanol exposure in an AD model. The increased brain glucose metabolism observed via PET may be attributed to ethanol stimulatory effects on neurotransmission and neuronal glucose uptake [6, 7]. However, the simultaneous decrease in RER suggests that peripheral tissues, particularly the liver and muscle, may compensate by shifting to fat oxidation, likely due to the energy demands of ethanol metabolism and its effect on hepatic lipid oxidation [8].
This metabolic disconnection, where the brain exhibits increased glucose uptake while peripheral tissues favor fat utilization, raises important questions about the systemic effects of ethanol in AD. This dissociation suggests ethanol disrupts central and peripheral energy homeostasis. The enhanced brain glucose uptake may offer short-term benefits, such as increased neuronal activity. However, the concurrent shift in peripheral metabolism could indicate systemic stress, particularly in organs like the liver, which are responsible for ethanol metabolism [4]. One potential explanation is that ethanol alters central and peripheral energy homeostasis through distinct mechanisms, with the brain prioritizing glucose for rapid energy needs. In contrast, peripheral tissues adjust to the energetic cost of metabolizing ethanol [9, 10]. The limitation of our studies includes the lacking wild-type control and potential confounding caloric effects of ethanol in CLAMS experiment.
Moderate ethanol exposure in an AD mouse model increases brain glucose metabolism and a concurrent shift toward peripheral fat oxidation. These results suggest a metabolic dissociation between brain and peripheral energy regulation, providing new insights into the complex role of metabolic dysfunction in AD. Ethanol-induced metabolic dissociation may involve AMPK and insulin signaling pathways. AMPK activation in peripheral tissues promotes fat oxidation, aligning with the observed reduction in RER, while its activation in the brain enhances glucose uptake, explaining the increased SUVR in FDG-PET scans [11].
Given that AUD has been linked to cognitive decline and increased amyloid accumulation in aging populations, particularly those over 65 [12], future research should investigate how these changes exacerbate disease progression and whether similar metabolic shifts occur in human AD patients.
Data availability
All data generated and/or analyzed during this study are included in this published article and its supplementary information. (Zenodo: https://zenodo.org/records/14969159).
Change history
08 March 2023
The Acknowledgements section was incomplete in the original publication, this article has been updated.
Abbreviations
- AD:
-
Alzheimer’s disease
- FDG:
-
Fluorodeoxyglucose
- PET:
-
Positron emission tomography
- CLAMS:
-
Comprehensive Lab Animal Monitoring System
- RER:
-
RRespiratory exchange ratio
- SUVR:
-
Standard uptake value ratio
References
Xu L, Liu R, Qin Y, Wang T. Brain metabolism in Alzheimer’s disease: biological mechanisms of exercise. Transl Neurodegener. 2023;12(1):33.
Yan X, Hu Y, Wang B, Wang S, Zhang X. Metabolic dysregulation contributes to the progression of Alzheimer’s disease. Front Neurosci. 2020;14:530219.
Jacob A, Wang P. Alcohol intoxication and cognition: implications on mechanisms and therapeutic strategies. Front Neurosci. 2020;14:102.
Kang S, Lee J, Ali DN, Choi S, Nesbitt J, Min PH, Trushina E, Choi DS. Low to moderate ethanol exposure reduces astrocyte-induced neuroinflammatory signaling and cognitive decline in presymptomatic APP/PS1 mice. Sci Rep. 2024;14(1):23989.
Khan MAS, Chang SL. Alcohol and the Brain-Gut axis: the involvement of microglia and enteric glia in the process of Neuro-Enteric inflammation. Cells 2023; 12(20).
Bingham EM, Hopkins D, Smith D, Pernet A, Hallett W, Reed L, Marsden PK, Amiel SA. The role of insulin in human brain glucose metabolism: an 18fluoro-deoxyglucose positron emission tomography study. Diabetes. 2002;51(12):3384–90.
Blazquez E, Hurtado-Carneiro V, LeBaut-Ayuso Y, Velazquez E, Garcia-Garcia L, Gomez-Oliver F, Ruiz-Albusac JM, Avila J, Pozo MA. Significance of brain glucose hypometabolism, altered insulin signal transduction, and insulin resistance in several neurological diseases. Front Endocrinol (Lausanne). 2022;13:873301.
Yang L, Yang C, Thomes PG, Kharbanda KK, Casey CA, McNiven MA, Donohue TM Jr. Lipophagy and Alcohol-Induced fatty liver. Front Pharmacol. 2019;10:495.
Chapp AD, Shan Z, Chen QH. Acetic acid: an underestimated metabolite in Ethanol-Induced changes in regulating cardiovascular function. Antioxid (Basel) 2024,; 13(2).
Pani G, Koch OR, Galeotti T. Molecular and genetic aspects of ethanol in human diet: a nutrient or a toxicant? Genes Nutr. 2010;5(2):97–9.
Muraleedharan R, Dasgupta B. AMPK in the brain: its roles in glucose and neural metabolism. FEBS J. 2022;289(8):2247–62.
Essa H, Ali HM, Min PH, Ali DN, Lowe V, Petersen RC, Knopman DS, Lundt ES, Mester CT, Bormann NL et al. Impact of alcohol use disorder on cognition in correlation with aging: a community-based retrospective cohort study. Alcohol Alcohol 2024; 60(1).
Acknowledgements
We thank all the laboratory members for their helpful discussion and comments. In particular, we would like to thank Dr. Eugenia Trushina (Mayo Clinic) for providing the APP/PS1 mice used in this study, which were generated and genotyped by her team to ensure rigor, reproducibility, and statistical power.
Funding
This research was supported by the Samuel C. Johnson for Genomics of Addiction Program at Mayo Clinic, the Soonchunhyang University (2025-007), Ulm Foundation, and the National Institute of Health (AG072898, AA029258).
Author information
Authors and Affiliations
Contributions
SK and DSC designed research; SK performed all the experiments; JL and PM carried out the FDG-PET experiment; SC did mice breeding and husbandry; SK and DSC analyzed data; SK and DSC wrote the paper.
Corresponding authors
Ethics declarations
Ethics approval and consent to participate
All animal experiments were approved by the Institutional Animal Care and Use Committee of the Mayo Clinic.
Consent for publication
Not applicable.
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Kang, S., Lee, J., Min, P.H. et al. Moderate ethanol exposure disrupts energy homeostasis between central and peripheral system in APP/PS1 mice. Mol Brain 18, 21 (2025). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13041-025-01192-z
Received:
Accepted:
Published:
DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13041-025-01192-z